Latest liver cancer News

Targeted liver cancer treatment kills cancer cells and cuts chemo side effects
Breakthrough Discovery In Fight Against Liver Disease
Ride For Lily To Support Children’s Brain Cancer Research
WHO publishes new guidelines on hepatitis B
Insights from patient who cleared hepatitis C could lead to vaccine
Study Shows How Oestrogen Protects Against Fatty Liver
Novel combination therapy offers promising results for treatment-refractory hepatoblastoma
King Charles is having cancer treatment. What can he, and others with cancer, expect?
Imfinzi plus transarterial chemoembolisation (TACE) and bevacizumab reduced the risk of disease progression or death by 23% vs. TACE in liver cancer…
Global study to spur new liver cirrhosis medicines
More screening vigilance needed to fight chronic liver disease
New approaches to blood and liver cancer therapies recognised with $2.5 million CSL Centenary Fellowships
New treatment offers hope for advanced liver cancer
$2m funding boost for innovative health and medical projects
New discovery for treatment of primary liver cancer
$4.3 million to kick start ground-breaking health and medical ideas
WHO launches “One life, one liver” campaign on World Hepatitis Day
No excuses on World Hepatitis Day, hepatitis can’t wait
Does artificial sweetener aspartame really cause cancer? What the WHO listing means for your diet soft drink habit
Aspartame hazard and risk assessment results released
Imfinzi plus Imjudo demonstrated sustained overall survival benefit in advanced liver cancer with an unprecedented one in four patients alive at four…
Manchester researchers awarded £1 million to test potential life-saving technology for early detection of liver cancer
AstraZeneca will highlight momentum of practice-changing cancer medicines across its robust pipeline at ASCO 2023
Hep C can be cured but many people are still not being treated
80 Marathons in 80 days for life-saving cancer research
Treating liver disease – NHRMC funding boost
5 things to know about liver cancer
AstraZeneca advances its pipeline and highlights progress in immuno-oncology, ADCs, cell therapy and epigenetics at AACR
Curtin researchers map genetic signature of precursor to liver cancer
Denise and Graeme’s Love and support throughout their cancer experience
Alex Jalloh remembers bond he had with his twin brother
Baylor receives more than $5.8 million in CPRIT funding
Dramatic rise in liver cancer in Australia’s tropical and equatorial north
Mary feels at home at Mater
EC Australia to continue beyond 2022
Seven QIMR Berghofer research projects awarded prestigious national grants
Australia falling behind in goal to eliminate hepatitis C, new report shows
Resignation of Cr John Watson
Associate Professor Jessica Howell is VCCC Alliance’s inaugural Tony Burgess medallist
Burnet awarded grant to develop next generation liver test
Professor Jacob George’s vision for liver cancer
New treatment principle for chronic hepatitis B and D infections
AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022
Why have so few Australians heard of MAFLD?
NSW new hepatitis can’t wait
Kiwis urged to ‘Stick it to hep C’ with launch of national hepatitis C awareness campaign
Trialling non-invasive liver cancer treatment
AGA recommends shared decision-making approach for treatment of hepatocellular carcinoma